G6PD and COVID-19: This is strongly suggested by the following evidence: (1) G6PD deficiency enhances several viral infections; (2) G6PD variants may impact COVID-19 severity; and (3) higher incidence of COVID-19 in African-Americans, whose G6PD deficiency is characterized by higher oxidative stress [111,112,113,114].